The University of Southampton
University of Southampton Institutional Repository

Rapid syndromic molecular testing in pneumonia: the current landscape and future potential

Rapid syndromic molecular testing in pneumonia: the current landscape and future potential
Rapid syndromic molecular testing in pneumonia: the current landscape and future potential
Community acquired pneumonia (CAP), hospital-acquired pneumonia (HAP) and ventilator associated pneumonia (VAP) are all associated with significant mortality and cause huge expense to health care services around the world. Early, appropriate antimicrobial therapy is crucial for effective treatment. Syndromic diagnostic testing using novel, rapid multiplexed molecular platforms represents a new opportunity for rapidly targeted antimicrobial therapy to improve patient outcomes and facilitate antibiotic stewardship. In this article we review the currently available testing platforms and discuss the potential benefits and pitfalls of rapid testing in pneumonia.
0163-4453
Poole, Stephen
440d7904-ab72-469c-892b-c910cd1cb19b
Clark, Tristan
712ec18e-613c-45df-a013-c8a22834e14f
Poole, Stephen
440d7904-ab72-469c-892b-c910cd1cb19b
Clark, Tristan
712ec18e-613c-45df-a013-c8a22834e14f

Poole, Stephen and Clark, Tristan (2019) Rapid syndromic molecular testing in pneumonia: the current landscape and future potential. Journal of Infection. (doi:10.1016/j.jinf.2019.11.021).

Record type: Article

Abstract

Community acquired pneumonia (CAP), hospital-acquired pneumonia (HAP) and ventilator associated pneumonia (VAP) are all associated with significant mortality and cause huge expense to health care services around the world. Early, appropriate antimicrobial therapy is crucial for effective treatment. Syndromic diagnostic testing using novel, rapid multiplexed molecular platforms represents a new opportunity for rapidly targeted antimicrobial therapy to improve patient outcomes and facilitate antibiotic stewardship. In this article we review the currently available testing platforms and discuss the potential benefits and pitfalls of rapid testing in pneumonia.

Text
1-s2.0-S016344531930372X-main - Accepted Manuscript
Download (962kB)

More information

Accepted/In Press date: 29 November 2019
e-pub ahead of print date: 3 December 2019

Identifiers

Local EPrints ID: 436774
URI: http://eprints.soton.ac.uk/id/eprint/436774
ISSN: 0163-4453
PURE UUID: f2e2faa5-3f73-4829-9406-684fe82c3ad5
ORCID for Tristan Clark: ORCID iD orcid.org/0000-0001-6026-5295

Catalogue record

Date deposited: 07 Jan 2020 17:32
Last modified: 17 Mar 2024 05:07

Export record

Altmetrics

Contributors

Author: Stephen Poole
Author: Tristan Clark ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×